Stock Market Live Updates: Markets close at record highs

In This Article:

Follow Yahoo Finance here for up-to-the-minute briefings on the financial markets, breaking news and other topics of interest to investors and traders. Please check back for continuing coverage.

4:03 p.m. ET: Stocks close at record highs

The Dow, Nasdaq, and S&P 500 closed at record highs, driven in part by record closes by Disney (DIS), Microsoft (MSFT), and JPMorgan Chase (JPM), according to a Yahoo Finance Analysis. Merck (MRK) also saw a boost, trading near record highs.

Here’s where markets settled at the end of regular equity trading Tuesday:

  • S&P 500 (^GSPC): +0.22%, or 6.79 points

  • Dow (^DJI): +0.19%, or 54.33 points

  • Nasdaq (^IXIC): +0.18%, or 15.44 points

  • 10-year Treasury yield (^TNX): -2.8 bp to 1.738%

  • Gold (GC=F): +0.36% to $1,462.20 per ounce

3:11 p.m. ET: SoulCycle CEO Melanie Whelan resigns

Melanie Whelan, CEO of private fitness company SoulCycle is resigning, effective Tuesday, the company told CNBC. The company did not say why.

“I’m deeply grateful for the opportunity to have led the SoulCycle team and brand over the past nearly eight years during a transformational time for this amazing community,” Whelan said in a statement to CNBC. “The future is bright for this one-of-a-kind organization and I will be cheering on its continued growth and success.”

1 p.m. ET: Federal prosecutors open criminal opioid probe, WSJ reports

The logo for Teva appears above a trading post on the floor of the New York Stock Exchange, Monday, Oct. 21, 2019. The nation's three dominant drug distributors and a big drugmaker have reached an over $200 million deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday. Drugmaker Teva would contribute $20 million in cash and $20 million worth of suboxone, a drug used to treat opioid addiction. (AP Photo/Richard Drew)
The logo for Teva appears above a trading post on the floor of the New York Stock Exchange, Monday, Oct. 21, 2019. The nation's three dominant drug distributors and a big drugmaker have reached an over $200 million deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday. Drugmaker Teva would contribute $20 million in cash and $20 million worth of suboxone, a drug used to treat opioid addiction. (AP Photo/Richard Drew)

The Wall Street Journal is reporting that federal prosecutors have opened a criminal investigation into pharma companies, and whether they “intentionally allowed” the painkillers to flood communities. Key drugmakers like Teva (TEVA) and McKesson (MCK) are dropping on the news, while Johnson & Johnson (JNJ) is marginally lower.

From The Journal’s story:

“Federal prosecutors have opened a criminal investigation into whether pharmaceutical companies intentionally allowed opioid painkillers to flood communities, employing laws normally used to go after drug dealers, according to people familiar with the matter.